Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-23

Clinical Trial Update: Probiotics in the Treatment of Irritable Bowel Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 study evaluating probiotics for Irritable Bowel Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic (probiotic)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: COMPLETED